MedTrace Logo

Impact of Bright Light Therapy on Prader-Willi Syndrome

NCT05939453 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-15

No results posted yet for this study

Summary

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

Conditions

Interventions

OTHER

Sham Light

Sham treatment will be provided from a light box at a distance of at least 70cm but no greater than 90cm.

OTHER

Bright Light Therapy

Bright Light Therapy will be provided using light box with an artificial full spectrum lamp at a distance of at least 70cm but no greater than 90cm.

Sponsors & Collaborators

  • Foundation for Prader-Willi Research

    collaborator OTHER

  • Maimonides Medical Center

    lead OTHER

Principal Investigators

  • Edward Yi, MD · Maimonides Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05939453 on ClinicalTrials.gov